Researcher
Adrian Teo Kee Keong pursued his PhD degree at the University of Cambridge, UK, and returned to Singapore in 2010, joining A*STAR’s Institute of Medical Biology (IMB) as a postdoctoral fellow. In 2011, he moved to the Joslin Diabetes Center at Harvard Medical School, US, under the Juvenile Diabetes Research Foundation fellowship and secured two Harvard Stem Cell Institute seed grants to pursue research on human pluripotent stem cells for in vitro disease modeling of diabetes. Adrian is currently a Principal Investigator at the Institute of Molecular and Cell Biology (IMCB), A*STAR; an Assistant Professor at the Yong Loo Lin School of Medicine, National University of Singapore; and an Adjunct Assistant Professor at the School of Biological Sciences, Nanyang Technological University, Singapore.
Related Articles
A closer look at metformin in maternal diabetes
25 Jan 2022New data suggest that metformin administered to pregnant mothers may have unintended effects on the
Opening the cellular gates to glucose
2 Jul 2021Low levels of sugar entering into pancreatic cells may be the culprit behind insulin secretion
Weaponizing stem cells in the war on diabetes
11 Dec 2019From replacing the insulin producing cells of the body, to serving as genetic and drug
Getting to the roots of early-onset diabetes
23 Aug 2019Mutations in the gene HNF4A impair liver and pancreas development, indicating that maturity-onset diabetes of